[1]班春霞,孟美玲,倪章春,等.高频重复经颅磁刺激在抑郁症急性期患者治疗中的增效作用[J].新乡医学院学报,2022,39(11):1055-1059.[doi:10.7683/xxyxyxb.2022.11.011]
　BAN Chunxia,MENG Meiling,NI Zhangchun,et al.Synergistic effect of high-frequency repetitive transcranial magnetic stimulation in the treatment of patients with acute depression[J].Journal of Xinxiang Medical University,2022,39(11):1055-1059.[doi:10.7683/xxyxyxb.2022.11.011]
点击复制

高频重复经颅磁刺激在抑郁症急性期患者治疗中的增效作用
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年11
页码:
1055-1059
栏目:
临床研究
出版日期:
2022-11-05

文章信息/Info

Title:
Synergistic effect of high-frequency repetitive transcranial magnetic stimulation in the treatment of patients with acute depression
作者:
班春霞1; 孟美玲1; 倪章春1; 于伟霞1; 王湖1; 陈翔春1; 汪崇泽2
（1.上海市嘉定区精神卫生中心精神科，上海　201806；2.上海交通大学医学院附属精神卫生中心临床六科，上海　200030）
Author(s):
BAN Chunxia1; MENG Meiling1; NI Zhangchun1; YU Weixia1; WANG Hu1; CHEN Xiangchun1; WANG Chongze2
(1.Department of Psychiatry,Mental Health Center of Jiading District in Shanghai,Shanghai 201806,China;2.The Six Clinical Departments，Shanghai Mental Health Center Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200030,China)
关键词:
抑郁症; 重复经颅磁刺激; 帕罗西汀
Keywords:
depression; repetitive transcranial magnetic stimulation; paroxetine
分类号:
R749.4
DOI:
10.7683/xxyxyxb.2022.11.011
文献标志码:
A
摘要:
目的　探讨高频重复经颅磁刺激（rTMS）在抑郁症急性期治疗中的增效作用。方法　选择2020年1月至2021年9月上海市嘉定区精神卫生中心和上海交通大学医学院附属精神卫生中心收治的94例抑郁症急性期患者为研究对象，根据治疗方法将患者分为对照组（n=48）和观察组（n=46）。观察组患者给予帕罗西汀联合rTMS治疗，对照组患者单用帕罗西汀治疗。分别于治疗前及治疗1、2、3周末，采用汉密尔顿抑郁量表（HAMD-24）评分评估2组患者抑郁症状。分别于治疗前和治疗3周末，采用临床总体印象量表-疾病严重度（CGI-S）量表评估2组患者病情严重程度。比较2组患者的临床疗效和治疗期间不良反应发生情况。结果　2组患者的HAMD-24评分随治疗时间延长显著降低（F=206.83、308.98，P<0.001）。治疗前，观察组与对照组患者的HAMD-24评分比较差异无统计学意义（P>0.05）；治疗1、2、3周末，观察组患者的HAMD-24评分均显著低于对照组（P<0.05）。2组患者治疗3周末CGI-S评分显著低于治疗前（P<0.05）；治疗前，对照组与观察组患者的CGI-S评分比较差异无统计学意义（P>0.05）；治疗3周末，观察组患者的CGI-S评分显著低于对照组（P<0.01）。治疗1周末，观察组患者治疗好转率高于对照组（χ2=4.876，P<0.05）；治疗2、3周末，观察组患者治疗有效率均高于对照组（χ2=7.153、5.041，P<0.05）；治疗3周末，观察组患者治疗临床痊愈率高于对照组（χ2=4.055，P<0.05）。对照组与观察组患者的不良反应发生率分别为16.7%（8/48）、19.6%（9/46）；对照组与观察组患者的不良反应发生率比较差异无统计学意义（χ2=0.133，P>0.05）。结论　高频rTMS联合帕罗西汀治疗抑郁症急性期起效快，高频rTMS对抑郁症急性期治疗具有一定的增效作用，且安全性较高。
Abstract:
Objective　To investigate the synergistic effect of high-frequency repetitive transcranial magnetic stimulation (rTMS) in the treatment of patients with acute depression.Methods　A total of 94 patients with acute depression admitted to Mental Health Center of Jiading District of Shanghai and Shanghai Mental Health Center Affiliated to Shanghai Jiao Tong University School of Medicine from January 2020 to September 2021 were selected as the research objects,and the patients were divided into the control group (n=48) and observation group (n=46) according to the treatment method.The patients in the observation group were treated with paroxetine combined with rTMS,while the patients in the control group were treated with paroxetine alone.The depressive symptoms of patients in the two groups was evaluated by Hamilton depression scale (HAMD-24) score before treatment and at the end of 1,2,3 weeks of treatment.Before treatment and at the end of 3 weeks of treatment,the severity of illness of patients in the two groups was evaluated by the clinical global impression-severity (CGI-S) scale.The clinical efficacy and adverse reactions during treatment were compared between the two groups.Results　The HAMD-24 scores of patients in the two groups were significantly decreased with the extension of treatment time（F=206.83,308.98;P<0.001).Before treatment,there was no significant difference in HAMD-24 score of patients between the observation group and the control group (P>0.05).At the end of 1,2 and 3 weeks of treatment,the HAMD-24 score of patients in the observation group was significantly lower than that in the control group (P<0.05).Before treatment,there was no significant difference in CGI-S score of patients between the control group and the observation group (P>0.05).The CGI-S score of patients at the end of 3 weeks of treatment was significantly lower than that before treatment in the two groups (P<0.05).At the end of 3 weeks of treatment,the CGI-S score of patients in the observation group was significantly lower than that in the control group (P<0.01).At the end of 1 week of treatment,the treatment improvement rate of patients in the observation group was significantly higher than that in the control group (χ2=4.876，P<0.05).At the end of 2 and 3 weeks of treatment,the effective rate of patients in the observation group was significantly higher than that in the control group (χ2=7.153,5.041;P<0.05).At the end of 3 weeks of treatment,the clinical recovery rate of patients in the observation group was significantly higher than that in the control group (χ2=4.055，P<0.05).The incidence of adverse reactions in the control group and the observation group were 16.7%(8/48) and 19.6%(9/46),respectively.There was no significant difference in the incidence of adverse reactions between the control group and the observation group (χ2=0.133,P>0.05).Conclusion　High-frequency rTMS combined with paroxetine has a rapid effect in the treatment of acute depression,high-frequency rTMS has a certain synergistic effect on the treatment of acute depression,and which has a high safety.

参考文献/References:

［1］　高丹青,马笑风.文拉法辛联合喹硫平治疗重度抑郁症急性期患者的疗效观察［J］.实用临床医药杂志,2020,24(1):62-65.
GAO D Q,MA X F.Effect observation of venlafaxine combined with quetiapine in the treatment of patients with severe depression in acute phase［J］.J Clin Med Pract,2020,24(1):62-65.
［2］　石奇嵩.文拉法辛联合喹硫平治疗重度抑郁症急性期的效果及对患者血清BDNF、Cor表达的影响［J］.中国医学创新,2021,18(13):139-142.
SHI Q S.Effect of venlafaxine combined with quetiapine in the treatment of acute stage of major depression and its effect on the expression of serum BDNF and Cor［J］.Med Innovat Chin,2021,18(13):139-142.
［3］　时玉东,张凯,刘寰忠.氯胺酮及其异构体和代谢物抗抑郁研究进展［J］. 中国神经精神疾病杂志,2020,46(9):565-568.
SHI Y D,ZHANG K,LIU H Z.Research progress of ketamine and its isoforms and metabolites in antidepressant［J］.Chin J Nerv Ment Dis,2020,46(9):565-568.
［4］　苑杰,李心桐,刘颖,等.抗抑郁药物起效时间的研究进展［J］.神经疾病与精神卫生,2020,20(8):561-566.
YUAN J,LI X T,LIU Y,et al.Research progress of onset time of antidepressants［J］.J Neurosci Mental Health,2020,20(8):561-566.
［5］　TOULOUMIS C.The burden and the challenge of treatment-resistant depression［J］.Psychiatriki,2021,32(Suppl 1):11-14.
［6］　ABDELRAHMAN A A,NOAMAN M,FAWZY M,et al.A double-blind randomized clinical trial of high frequency rTMS over the DLPFC on nicotine dependence,anxiety and depression［J］.Sci Rep,2021,11(1):1640.
［7］　LEFAUCHEUR J P,ALEMAN A,BAEKEN C,et al.Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS):an update (2014-2018)［J］.Clin Neurophysiol,2020,131(2):474-528.
［8］　世界卫生组织.ICD-10 精神与行为障碍分类:临床描述与诊断要点［M］.范肖冬,汪向东,于欣,等.北京:人民卫生出版社,1993:25.
WORLD HEALTH ORGANIZATION.The ICD-10 classification of mental and behavioral disorders:clinical descriptions and diagnostic guidelines［M］.FAN X D,WANG X D,YU X,et al.Beijing:People′s Medical Publishing House,1993:25.
［9］　HAMILTON M.Rating depressive patients［J］.J Clin Psychiatry,1980,41(12Pt2):21-24.
［10］　GLAZER K,ROOTES-MURDY K,VAN WERT M,et al.The utility of PHQ-9 and CGI-S in measurement-based care for predicting suicidal ideation and behaviors［J］.J Affect Disord,2020,266:766-771.
［11］　CANUSO C M,IONESCU D F,LI X,et al.Esketamine nasal spray for the rapid reduction of depressive symptoms in major depressive disorder with acute suicidal ideation or behavior［J］.J Clin Psychopharmacol,2021,41(5):516-524.
［12］　HUANG Y,WANG Y,WANG H,et al.Prevalence of mental disorders in China:a cross-sectional epidemiological study［J］.Lancet Psychiatry,2019,6(3):211-224.
［13］　ZHOU J,WANG X,FENG L,et al.Venlafaxine vs.fluoxetine in postmenopausal women with major depressive disorder:an 8-week,randomized,single-blind,active-controlled study［J］.BMC Psychiatry,2021,21(1):260.
［14］　赵艳华.不同侧的背外侧前额叶重复经颅磁刺激治疗抑郁症疗效及对时间知觉的影响［J］.国际精神病学杂志,2019,46(5):825-827,840.
ZHAO Y H.Effect of repetitive transcranial magnetic stimulation in the dorsolateral prefrontal lobe on depression and time perception［J］.J Int Psychiatry,2019,46(5):825-827,840.
［15］　CORLIER J,BURNETTE E,WILSON A C,et al.Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control［J］.J Affect Disord,2020,265:272-277.
［16］　BULTEAU S,LAURIN A,PERE M,et al.Intermittent theta burst stimulation (iTBS) versus 10 Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) to alleviate treatment-resistant unipolar depression:a randomized controlled trial (THETA-DEP)［J］.Brain Stimul,2022,15(3):870-880.
［17］　O′REARDON J P,SOLVASON H B,JANICAK P G,et al.Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression:a multisite randomized controlled trial［J］.Biol Psychiatry,2007,62(11):1208-1216.
［18］　ZHANG L,ZHU J,ZHANG T,et al.Comparative efficacy of add-on rTMS in treating the somatic and psychic anxiety symptoms of depression comorbid with anxiety in adolescents,adults,and elderly patients:a real-world clinical application［J］.J Affect Disord,2020,276:305-311.
［19］　胡晓月,潘伟刚,马辛,等.重复经颅磁刺激联合抗抑郁药治疗首次发病老年抑郁症的初步研究［J］.中华精神科杂志,2021,54(4):265-270.
HU X Y,PAN W G,MA X,et al.A preliminary study of repetitive transcranial magnetic stimulation combined with antidepressants in the treatment of first episode late life depression［J］.Chin J Psychiatry,2021,54(4):265-270.
［20］　MANEETON B,MANEETON N,WOOTTILUK P,et al.Repetitive transcranial magnetic stimulation combined with antidepressants for the first episode of major depressive disorder［J］.Curr Neuropharmacol,2020,18(9):852-860.
［21］　RUMI D O,GATTAZ W F,RIGONATTI S P,et al.Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression:a double-blind placebo-controlled study［J］.Biol Psychiatry,2005,57(2):162-166.
［22］　孙丛丛,吴涵,周丹娜,等.脑源性神经营养因子对经颅磁刺激治疗难治性抑郁症的疗效预测作用［J］.首都医科大学学报,2022,43(2):227-332.
SUN C C,WU H,ZHOU D N,et al.Brain derived neurotrophic factor as the predictor of efficacy for repetitive transcranial magnetic stimulation in the treatment of refractory depression［J］.J Capital Med Univ,2022,43(2):227-232.

相似文献/References:

[1]陈佐明,张建宏,张秀明,等.单次发作抑郁症过氧化脂质及谷胱甘肽过氧化物酶检测的意义[J].新乡医学院学报,1995,12(02):153.
[2]梁炜,陈佐明,张留莎.氟西汀与丙咪嗪治疗抑郁症的对照研究[J].新乡医学院学报,2000,17(02):102.
[3]孟 焱,杜 江,王 萍.舍曲林与阿米替林治疗老年期抑郁症的双盲比较[J].新乡医学院学报,2002,19(03):181.
[4]孟 焱,杜 江,王 萍.舍曲林与阿米替林治疗老年期抑郁症的双盲比较[J].新乡医学院学报,2002,19(03):181.
[5]孟庆莉,谭 军.清热解躁汤治疗脑血管病后抑郁症31例[J].新乡医学院学报,2002,19(05):432.
[6]邹韶红,党海红,黄国平.抑郁症81例应对方式的性别差异 [J].新乡医学院学报,2004,21(01):000.
[7]张顺英,李臻,胡萌.家庭访视及护理指导对抑郁症患者综合依从性和疗效的影响[J].新乡医学院学报,2009,26(04):426.
[8]王长虹,李晏,谢春朋,等.抑郁症的神经内分泌研究进展[J].新乡医学院学报,2011,28(06):000.
[9]张小毅,李生莹,何益群,等.氟西汀对慢性温和应激抑郁模型大鼠海马神经干细胞的影响[J].新乡医学院学报,2012,29(11):818.
[10]赵利芹,李　晏,邵秋静,等.丰富环境对抑郁大鼠行为学及海马组织中丝裂原活化蛋白激酶磷酸酶-1表达的影响[J].新乡医学院学报,2017,34(9):798.[doi:10.7683/xxyxyxb.2017.09.005]
　ZHAO Li-qin,LI Yan,SHAO Qiu-jing,et al.Effects of enriched environment on behavior and expression of mitogen-activated protein kinase phosphatase-1 in hippocampus of depression rats[J].Journal of Xinxiang Medical University,2017,34(11):798.[doi:10.7683/xxyxyxb.2017.09.005]

更新日期/Last Update: 2022-11-05